Op-Eds/Commentaries
Congress needs to update FDA regulations on diagnostic tests and cosmetics
By Scott Gottlieb, MD and Mark B. McClellan, MD
Reforms Needed to Modernize the US Food and Drug Administration’s Oversight of Dietary Supplements, Cosmetics, and Diagnostic Tests
Scott Gottlieb, MD and Mark B. McClellan, MD, PhD
America needs a confirmed leader at FDA — now
Mark McClellan, Scott Gottlieb, and Margaret Hamburg and Andy Slavitt
We both led Medicare and Medicaid. Biden’s vaccine mandate for health-care workers must stand.
Mark McClellan and Andy Slavitt
Beyond ample supply, hurdles abound in the race to vaccinate the globe
Mark McClellan, Krishna Udayakumar, Michael Merson, and Gary Edson
We’re part of a planning group for a covid-19 commission. Here’s why we need one.
Marc Lipsitch, Mark McClellan and Robert Rodriguez
Why America’s Next Covid Push Should Be Outside America
Mark McClellan, Krishna Udayakumar, Michael Merson, Gary Edson
COVID Arsenal Needs Pills as Well as Shots
By Scott Gottlieb and Mark McClellan
What to Do When There’s a Covid-19 Vaccine Glut
By Scott Gottlieb and Mark McClellan
A Light Regulatory Touch to Keep Covid Drugs Current
Scott Gottlieb and Mark McClellan
Why Are Covid Antibody Drugs Sitting on Shelves?
By Scott Gottlieb and Mark McClellan
Deploying Big Data to Determine How Well Vaccines Work
Scott Gottlieb and Mark McClellan
It’s Now Up to Governors to Slow the Spread
Scott Gottlieb and Mark McClellan
Where Do I Go to Get My Covid Antibody Cocktail?
Scott Gottlieb and Mark McClellan
The Trump Treatment for Covid Is Coming Soon
By Scott Gottlieb and Mark McClellan
7 former FDA commissioners: The Trump administration is undermining the credibility of the FDA
Robert Califf, Scott Gottlieb, Margaret Hamburg, Jane Henney, David Kessler, Mark McClellan and Andy von Eschenbach
Building A Better Health Care System Post-Covid-19: Steps for Reducing Low-Value and Wasteful Care
Corinna Sorenson, Ph.D., MHSA, MPH Mark Japinga, MPA, Hannah Crook, Mark McClellan, MD, Ph.D.
Wall Street Journal Op-Ed: Rules for Clinical Trials in a Pandemic
Scott Gottlieb and Mark McClellan
USA Today Op-Ed: Health leaders: Let’s #OpenSafely
Andy Slavitt and Dr. Mark McClellan
